Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
The American journal of gastroenterology, 2020-08, Vol.115 (8), p.1286-1288
Ort / Verlag
United States: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Erscheinungsjahr
2020
Quelle
MEDLINE
Beschreibungen/Notizen
Although coronavirus disease (COVID-19) has been associated with gastrointestinal manifestations, its effect on the pancreas remains unclear. We aimed to assess the frequency and characteristics of hyperlipasemia in patients with COVID-19.
A retrospective cohort study of hospitalized patients across 6 US centers with COVID-19.
Of 71 patients, 9 (12.1%) developed hyperlipasemia, with 2 (2.8%) greater than 3 times upper limit of normal. No patient developed acute pancreatitis. Hyperlipasemia was not associated with poor outcomes or symptoms.
Although a mild elevation in serum lipase was observed in some patients with COVID-19, clinical acute pancreatitis was not seen.